Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting
Rocaltrol® City Tour·Fuzhou Station
On June 18, 2023, the third stop of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting and Rocaltrol® City Tour” co-sponsored by Pharmanovia & Hessina was successfully held in Fuzhou Grand Hotel. The establishment of Rocaltrol ® City Tour Project aims to enhance the guiding role of the “Guidelines” for clinicians through the form of city tours, and combine the latest clinical experience and methods in the standardized diagnosis and treatment of osteoporosis to help people at all levels The hospital improves the standardized diagnosis and treatment of osteoporosis and patient management, and hopes to take this opportunity to learn, exchange, and discuss together, so as to maximize its social responsibility of fighting osteoporosis, serving the clinic, and benefiting patients.
Professor Yan Sunjie , Chairman of the conference, director of the Department of Endocrinology, the First Affiliated Hospital of Fujian Medical University
Professor Yan first thanked everyone for participating in this meeting. Fuzhou is the third stop of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting and Rocaltrol® City Tour”, which illustrates the importance of osteoporosis in Fujian Province. The emphasis on diagnosis and treatment and being at the forefront of the field of osteoporosis also hope that more clinicians and researchers can better understand the new progress, new guidelines and new evidence-based medical evidence in the field of osteoporosis diagnosis and treatment through the interpretation. The power of multiple disciplines such as clinic and laboratory will jointly empower the standardized diagnosis and treatment of osteoporosis in Fujian Province.”
Professor Shi Xiulin , Conference Speaker Deputy Director of Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University
As the first speaker of this conference, Professor Shi Xiulin shared the diagnosis and differential diagnosis of osteoporosis. Professor Shi introduced the diagnostic criteria of the new version of the guidelines, combined with nearly ten clinical cases in the department, provided many new ideas for diagnosis and differential diagnosis to the doctors present, and pointed out six unusual differential diagnoses: unusual bone pain, unusual Unusual age, unusual level of bone turnover, unusual treatment response, unusual course of disease, and unusual family history.
Professor Cai Siqing , Conference Speaker Administrative Director, Department of Radiology, The Second Affiliated Hospital of Fujian Medical University
As an expert in the Department of Radiology, Professor Cai explained the standard report and misunderstandings of bone density examination from the perspective of imaging. According to the requirements of the new version of the guidelines, he pointed out some wrong terminology, such as the grading of osteoporosis, only low bone mass , Osteoporosis and severe osteoporosis, there is no expression of moderate or severe osteoporosis, and the principle of bone density examination is low, not high, and osteoporosis can be diagnosed if there is a brittle fracture. Professor Cai pointed out that patients with hyperparathyroidism, diabetes and obesity are more suitable for forearm bone density testing. Linglong dual-energy X-ray bone densitometer is small, easy to install and operate, and is quite suitable for screening and use at the grassroots level.
Professor Luo Li , Speaker of the conference, deputy director of the Department of Hypertension, Department of Geriatrics, and the Second Department of Cadres of the First Affiliated Hospital of Fujian Medical University
Finally, Professor Luo Li shared the risks and harms of osteoporotic fractures, anti-osteoporosis drug treatment and the role of Vit D in the treatment of osteoporotic fractures. Professor Luo emphasized that calcitriol (Rocaltrol) does not require the activation of liver and kidney hydroxylation, it can improve bone density in patients with osteoporosis, increase muscle strength in patients with osteoporosis, prevent falls and reduce the incidence of fractures. “Guidelines for Perioperative Intervention of Osteoporotic Fractures” recommends active Vit D as the basic perioperative medication for patients with osteoporotic fractures.
Professor Yan presided over the final discussion session and commented on the meeting. He mentioned that the lecturer’s courseware not only shared guideline updates, but also showed more clinical cases, which I believe will benefit many doctors a lot. During the questioning session, the guests asked the three speakers about the problems they encountered in their clinical work, and the three speakers answered their questions, and the atmosphere of academic exchanges was strong. The participants expressed that they had gained a lot of cutting-edge information related to the diagnosis and treatment of osteoporosis through this meeting, and had a deeper understanding of the diagnosis and treatment of osteoporosis.
